SEC Filing Summary for Baxter International Inc.

This filing details stock options granted to James Teaff, President of CCS at Baxter International Inc. The options, exercisable in three equal annual installments, have varying exercise dates and prices. The earliest option, granted on March 5, 2017, became exercisable on March 5, 2018, with an exercise price of $50.77. The latest option detailed, with an exercise date of March 1, 2027, has an expiration date of February 27, 2036, and an exercise price of $20.37. The filing also reports direct ownership of 31,120 shares of common stock.